D-0854-2021 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-0854-2021 was initiated by American Health Packaging on Sep 15, 2021 and is designated Class II. Reason for recall: CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms. The recall status is terminated (terminated Jun 8, 2023). Affected quantity: 548 ccases.

Recall details

Product Type
Drugs
Report Date
Oct 6, 2021
Initiation Date
Sep 15, 2021
Termination Date
Jun 8, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
548 ccases

Product description

Valproic Acid Oral Solution, USP, 500 mg/10 mL, 100 10 mL unit dose cups per case, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217 Case NDC#: 60687-262-56; Individual Dose NDC: 60687-262-42

Reason for recall

CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Distribution pattern

Nationwide USA

Code information

Lot 1000082; Exp 06/30/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0854-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0854-2021. Report a data issue: hello@regdatalab.com.